Your privacy is very important for us. When you visit our website, please agree to the use of all cookies. For more information about the processing of personal data, please go to Privacy policy

com_logo.svg

DUNCAN DENG

Counsel
  • Contact

    +86 152 1072 7446

    duncan.deng@ruiminlaw.com

  • Shanghai

    Unit 603, 605, 606, Level 6, 8 Century Avenue, HSBC Building, Pudong New Area Shanghai 200120 China

    Shenzhen

    45/F, China Resources Tower, No.2666 Keyuan South Road, Yuehai Street, Nanshan District, Shenzhen

d1_1img10.jpg

Duncan Deng is a counsel at RuiMin. His primary practice areas include M&A, private equity and general corporate matters, with a particular focus on deals in the healthcare and life science sectors.


Before joining RuiMin, Duncan worked at the Beijing and Shenzhen offices of the leading Chinese firm Fangda Partners for six years.

Duncan speaks fluent Mandarin and English.


  • Experience

    • Advising AstraZeneca on its US$1.2bn acquisition of  Nasdaq-listed Gracell Biotechnology (ALB China 2024 M&A Deal of the Year Award)

    • Advising DP World, a world leader in global supply chain solutions based in Dubai, on its acquisition of 100 per cent of theCargo Services Seafreightbusiness, a comprehensive logistics solutions provider

    • Advising CVC Capital Partners, on its acquisition of Scan  Global Logistics(SGL),a globalfull-service logistics providerleading international freight forwarder,Scan Glwith an enterprise value of US$1.67obal Logistics. The gross valuation of the deal is US$1.5bn

    • Advising OSRAM, on its sale of digital systems business to an A-share listed company Inventronics (SZSE:300582.SZ)

    • Advising Ericsson (NASDAQ:ERIC), on theitssale of itsInternet of Things Accelerator (IoTA) and Connected Vehicle Cloud (CVC) businesses to Aeris Communications, Inc

    • Advising Alibaba Group, Ant Group, Ali Health, Cainiao, Ele.me on their investments in target companies covering a wide range of industry sectors including TMT, healthcare, entertainment, advertising, transportation and logistics  

    • Advising Morgan Stanley Private Equity Asia on its acquisition of a public hospital in Jiangsu Province and providing legal services in the daily operation and subsequent sale of controlling equity interests to CR Medical (01515.HK)

    • Advising Lumentum Holdings Inc. (NASDAQ:LITE) and providing PRC legal service in connection withon its US$918m acquisition of NeoPhotonics Corporation (NYSE:NPTN)

    • Advising Blue Sail Medical (002382.SZ) on its RMB5.9bn acquisition of Biosensors International Group, one of the largest manufacturers and suppliers of cardiovascular stents globally

    • Advising Ping'an Ventures on its acquisition of  a high-end medical clinic in Shenzhen




  • Qualifications

    Duncan obtained both LLB and LLM degreesbachelor and master degrees in law from China University of Political Science & Law. He was a recipient of the Dr. Helmut Sohmen Scholarship at Southern Methodist University in Texas, from which he graduated and obtained an LLM degreemaster degree in law. He is qualified in China and the State of New York.